www.fdanews.com/articles/129407-cancer-drugmaker-tetralogic-pharma-raises-32-million

Cancer Drugmaker TetraLogic Pharma Raises $32 Million

August 12, 2010

TetraLogic Pharmaceuticals has completed a $32 million Series C fund-raise that the company will use to push its cancer drug through a Phase IIa study.
MedCity News